. 2013 Jan 24;8(1):e52950. doi: 10.1371/journal.pone.0052950

Table 2. Nevirapine plasma concentrations during follow-up 48 weeks.

	2W	4W	12W	24W	36W	48W
n	290	270	247	244	233	226
C_trough (µg/mL)	4.26 (IQR 3.05–5.61)	5.90 (IQR 4.54–8.14)	6.21 (IQR 4.68–8.15)	6.23 (IQR 4.56–8.47)	6.15 (IQR 4.51–8.07)	6.37 (IQR 4.72–8.64)
n	167	159	137	129	126	120
C_max (µg/mL)	5.07(IQR 3.92–6.44)	6.89 (IQR 5.23–8.84)	6.34 (IQR 4.72–8.03)	6.32 (IQR 5.40–7.85)	6.48 (IQR 5.19–8.35)	6.91 (IQR 5.49–8.56)

C_trough: trough concentration of nevirapine.

C_max: peak concentration of nevirapine.

Data were described as median (IQR: inter-quartile range).